Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Atypical facial pain in multiple sclerosis caused by spinal cord seizures: a case report and review of the literature.
Induction of regulatory T-cells from memory T-cells is perturbed during acute exacerbation of multiple sclerosis.
Oligodendrocyte development and myelination in GFP-transgenic zebrafish.
An Exploratory Investigation of Social Stigma and Concealment in Patients with Multiple Sclerosis.
Personality in multiple sclerosis (MS): impact on health, psychological well-being, coping, and overall quality of life.
Magnetic resonance imaging outcomes from a phase III trial of teriflunomide.
Immunology of Multiple Sclerosis.
Risk factors for convertion to clinically defined multiple sclerosis after clinically isolated syndrome in a racially mixed Brazilian cohort.
Treatment Options to Reduce Disease Activity After Natalizumab: Paradoxical Effects of Corticosteroids.
10% liquid human immunoglobulin (KIOVIG(®)) for immunomodulation in autoimmune disorders.
Effects of dimethyl fumarate on lymphocyte subsets.
Is No Evidence of Disease Activity a Realistic Goal for Patients With Multiple Sclerosis?
Oligodendrogliopathy in Multiple Sclerosis: Low Glycolytic Metabolic Rate Promotes Oligodendrocyte Survival.
UCSF Seminar: "The needle in the haystack: Searching for target antigens of the adaptive immune response in MS."
Effect of therapeutic horseback riding on balance and gait of people with multiple sclerosis.
The role of stem cell therapy in multiple sclerosis: An overview of the current status of the clinical studies.
Ncx3 gene ablation impairs oligodendrocyte precursor response and increases susceptibility to experimental autoimmune encephalomyelitis.
Treatment Burden and Chronic Illness: Who is at Most Risk?
Pediatric Multiple Sclerosis.
Convergence through Complexity: How to Cure Brain Disease; Orion Bionetworks 2nd Annual Conference
Dimethyl fumarate induces necroptosis in colon cancer cells through glutathione depletion/ROS increase/MAPKs activation pathway.
Pharmacokinetics and pharmacodynamics of IFN-beta 1a in healthy volunteers.
Developing a Valuation Function for the Preference-Based Multiple Sclerosis Index: Comparison of Standard Gamble and Rating Scale.
Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis.
Neurorehabilitation Topics in Patients with Multiple Sclerosis: From Outcome Measurements to Rehabilitation Interventions.

Pages